NTx Awarded Grant to Develop Novel Manufacturing Technologies for Improved Global Access to mRNA Vaccines and Therapeutics
NTx has received a grant from the Bill & Melinda Gates Foundation to develop new production approaches to lower the cost and improve access to mRNA vaccines and therapeutics for low- and middle-income countries
GelSight Expands its Board of Directors to Guide Transformation into Tactile Intelligence Platform Company
MAKO and Magic Leap founder Rony Abovitz and experienced executive and investor Elliot Katzman will help shape GelSight’s strategy and reach